A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumors
Clinical & Translational Immunology · 2026-04 · 15 (4)
DOI: 10.1002/cti2.70093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Translational Immunology, online erschienen am 09.04.2026. Verfasst von Bryan Gardam und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Health Adelaide University Adelaide SA Australia. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kids' Cancer Project, Cancer Australia.
Abstract (Originalsprache)
Objectives
Glioblastoma is characterised by poor survival with few treatment advances for over 20 years. Immunotherapies, which have transformed treatment of other cancers, have been difficult to apply to glioblastoma because of its highly immune‐suppressive microenvironment, and there is a growing appreciation that the disease also induces a global suppression of the systemic immune system. However, immunotherapy research is hampered by the lack of detailed characterisation of the whole immune system in murine brain tumor models, with studies until now having focussed mainly on tumor‐infiltrating immune cells.
Methods
Here, we have studied common murine models of intracranial brain tumors by using high‐parameter flow cytometry and tissue immunofluorescence staining to fully characterise immune cells in the brain, draining lymph node, spleen and bone marrow.
Results
The highly immune‐compromised NSG mouse models were striking in their many immune perturbations, which extended beyond the known deficits in lymphocytes. Immunocompetent tumor models had significant changes in brain‐resident immune cells compared to controls, as expected; however, systemic effects were also observed with significant reductions in subsets of monocytes, macrophages and dendritic cells in the spleen and increases in bone marrow.
Conclusion
Our extensive and quantitative characterisation of the immune system in murine models of glioblastoma will allow for a better‐informed selection of models and advance the search for new immune‐based treatments for this deadly disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, College of Health Adelaide University Adelaide SA Australia.
- Translational Oncology Laboratory, Centre for Cancer Biology, College of Health Adelaide University Adelaide SA Australia.
- Molecular Therapeutics Laboratory, Centre for Cancer Biology, College of Health Adelaide University Adelaide SA Australia.
- Cancer Clinical Trials Unit Royal Adelaide Hospital Adelaide SA Australia.
ORCID-Profile: Bryan Gardam
Förderung
- Kids' Cancer Project
- Cancer Australia
Zitieren
APA
Gardam, B., Nam, E., Kollis, P. M., Kilyen-Coles, J., Lenin, S., Gliddon, B. L., Tea, M. N., Pitson, S. M., Brown, M. P., Ebert, L. M., & Gargett, T. (2026). A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumors. Clinical & Translational Immunology, 15(4). https://doi.org/10.1002/cti2.70093
Vancouver
Gardam B, Nam E, Kollis PM, Kilyen-Coles J, Lenin S, Gliddon BL, et al. A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumors. Clinical & Translational Immunology. 2026;15(4). doi:10.1002/cti2.70093
BibTeX
@article{Gardam2026,
author = {Gardam, Bryan and Nam, Eunwoo and Kollis, Paris M and Kilyen-Coles, Jasmine and Lenin, S and Gliddon, Briony L and Tea, Melinda N and Pitson, Stuart M and Brown, Michael P and Ebert, Lisa M and Gargett, Tessa},
title = {A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumors},
journal = {Clinical & Translational Immunology},
year = {2026},
volume = {15},
number = {4},
doi = {10.1002/cti2.70093}
}
EUVIMED